- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 05.09. | MRM Health gains $64m for microbiome-based biotherapeutic pipeline | ||
| 05.09. | Gilead Sciences advances HIV prevention with new US partnership | ||
| 04.09. | Bavarian Nordic's Vimkunya makes UK debut amid Ixchiq suspension | ||
| 04.09. | No batch too small: Choosing the right fill-finish CDMO for small-scale batches | ||
| 04.09. | FDA creates new pathway for rare disease drugs, analysts unconvinced | ||
| 04.09. | Insmed scores pivotal win in bronchiectasis with FDA approval of Brinsupri | ||
| 04.09. | Novartis adds again to siRNA pipeline with second deal in a day | ||
| 04.09. | Avadel secures rights to develop valiloxybate globally | ||
| 04.09. | Health Canada approves AbbVie's Elahere for ovarian cancer | ||
| 03.09. | How to transform your clinical insights with real-world evidence (RWE) | ||
| 03.09. | Six key steps to successful technical transfers of high potent oral solid dose drugs | ||
| 03.09. | Novartis returns to alpha-synuclein with $2.2bn Arrowhead deal | ||
| 03.09. | Quotient Sciences and CPI to expedite RNA therapy development | ||
| 03.09. | Amgen to invest $600m in new US science and innovation hub | ||
| 02.09. | Chinese drugmakers prep for looming semaglutide generics horizon | ||
| 02.09. | Trump blames Covid-19 drugmakers for fuelling CDC turmoil | ||
| 02.09. | NVIDIA-backed Charm secures $80m to advance AML drug | ||
| 02.09. | Oxford University and Ellison Institute link for AI vaccine research | ||
| 02.09. | China's NMPA conditionally approves Boehringer's tablets for NSCLC | ||
| 01.09. | ESC 2025: Higher leg muscle scores reduce cardiovascular risk independent of BMI | ||
| 01.09. | CDMO insights podcast series: Our Experience is Your Strength | Episode #5 Sustainable packaging | ||
| 01.09. | Advancing diagnostics reagent development for emerging and rare diseases | ||
| 01.09. | ESC 2025: Novo Nordisk's Wegovy superior to Zepbound in reducing CV events | ||
| 01.09. | Eisai's Leqembi unlocks at-home dosing with FDA autoinjector approval | ||
| 01.09. | Santhera and Ikris sign distribution agreement for DMD drug in India |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .